However, the sensitivity of LAIR-1 expression as a noninvasive molecular marker in liquid biopsy is accepted for the detection of HCC progression from liver cirrhosis HCV G4-related infection, which opens the door for better screening of AFP-negative HCC transformation. Here, LAIR1 is linked to hepatocellular carcinoma.